Variant report
Variant | esv1807059 |
---|---|
Chromosome Location | chr4:45005852-45010969 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr4:45007075-45007175 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | EP300 | chr4:45007061-45007463 | GM12878 | blood: | n/a | n/a |
3 | FOS | chr4:45006934-45007248 | MCF10A-Er-Src | breast: | n/a | chr4:45007110-45007118 chr4:45007108-45007120 |
4 | FOS | chr4:45006927-45007497 | MCF10A-Er-Src | breast: | n/a | chr4:45007110-45007118 chr4:45007447-45007459 chr4:45007108-45007120 |
5 | FOS | chr4:45006975-45007191 | MCF10A-Er-Src | breast: | n/a | chr4:45007110-45007118 chr4:45007108-45007120 |
6 | MXI1 | chr4:45006585-45006604 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | NFIC | chr4:45006971-45007473 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr4:45006975-45007368 | H1-neurons | neurons: | n/a | n/a |
9 | POLR2A | chr4:45009439-45009558 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr4:45007001-45007384 | H1-neurons | neurons: | n/a | n/a |
11 | RUNX3 | chr4:45007183-45007597 | GM12878 | blood: | n/a | n/a |
12 | STAT3 | chr4:45006931-45007239 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr4:45006952-45007154 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr4:45006953-45007272 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:44999456..45001286-chr4:45006123..45008246,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248744 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4469117 | chr4:45005852-45005853 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563272239 | chr4:45005873-45005874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114577271 | chr4:45005930-45005931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187552393 | chr4:45005946-45005947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75014553 | chr4:45005999-45006000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528802167 | chr4:45006030-45006031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532446050 | chr4:45006048-45006049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547266956 | chr4:45006071-45006072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550259661 | chr4:45006114-45006115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568855057 | chr4:45006133-45006134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375861079 | chr4:45006148-45006149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535907869 | chr4:45006228-45006229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138767115 | chr4:45006236-45006237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569283376 | chr4:45006258-45006259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547917963 | chr4:45006298-45006299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75478219 | chr4:45006375-45006376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141227658 | chr4:45006403-45006404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74423034 | chr4:45006422-45006423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534171025 | chr4:45006435-45006436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573462167 | chr4:45006439-45006440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372604354 | chr4:45006461-45006462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114709848 | chr4:45006484-45006485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9884381 | chr4:45006507-45006508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs4377625 | chr4:45006516-45006517 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs544706976 | chr4:45006540-45006541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556887206 | chr4:45006562-45006563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575258978 | chr4:45006585-45006586 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs190902483 | chr4:45006594-45006595 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs556900255 | chr4:45006607-45006608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561467484 | chr4:45006671-45006672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576640803 | chr4:45006676-45006677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146945340 | chr4:45006687-45006688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182582650 | chr4:45006698-45006699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565477104 | chr4:45006714-45006715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532822554 | chr4:45006730-45006731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74442890 | chr4:45006753-45006754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561707193 | chr4:45006771-45006772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368588405 | chr4:45006784-45006785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116016094 | chr4:45006796-45006797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530143765 | chr4:45006814-45006815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4505863 | chr4:45006828-45006829 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs560613095 | chr4:45006838-45006839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73246817 | chr4:45006945-45006946 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs534548631 | chr4:45006988-45006989 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs74983770 | chr4:45006997-45006998 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs565092393 | chr4:45007008-45007009 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs367974383 | chr4:45007041-45007042 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs556691803 | chr4:45007091-45007092 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs575128330 | chr4:45007110-45007111 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs75545415 | chr4:45007148-45007149 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:44998800-45006200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:45006200-45008400 | Enhancers | HMEC | breast |
3 | chr4:45006200-45008600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:45006400-45006600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr4:45006400-45006800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:45006400-45007200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr4:45006400-45007400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr4:45006600-45007400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr4:45006800-45007400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr4:45007200-45007400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr4:45007200-45007400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:45007200-45007400 | Enhancers | NH-A | brain |
13 | chr4:45007400-45012800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr4:45007400-45012800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
15 | chr4:45009400-45009800 | Enhancers | Fetal Heart | heart |